Lexington Medical Center announced Lexington Medical Cancer Center’s Clinical Research and Education affiliation with MUSC Hollings Cancer Center in Charleston, SC. This partnership will provide Lexington Medical Center patients access to MUSC’s National Cancer Institute-designated clinical trials and continue to ensure they receive high quality and comprehensive cancer services.
Through this affiliation, Lexington Medical Cancer Center will work collaboratively with MUSC to advance the expertise of clinical staff and offer the latest in cancer treatment research. Specifically, the affiliation with MUSC Hollings Cancer Center will allow Lexington Medical Center’s patients access to more than 200 clinical trials, providing patients in the Midlands a wide range of the most promising cancer treatments currently available in the nation.
“As the Midlands’ only hospital providing comprehensive cancer care, we are excited about the benefits our affiliation with MUSC Hollings Cancer Center brings to our patients. Having access to their National Cancer Institute-designated clinical trials and research expertise will allow our patients to receive the latest, most innovative treatment while staying here in their community,” says Quillin Davis, MD, medical director of cancer services at Lexington Medical Center.
“MUSC Hollings Cancer Center is committed to improving the care of cancer patients across our state,” said David Zaas, M.D., MUSC Health Charleston Division CEO. “We are excited to partner with Lexington Medical Center to help ensure patients can access innovative clinical research trials and new approaches to care, including state of the art therapies closer to home.”
MUSC Hollings Cancer Center is home to more than 120 scientists conducting research and collaborating on better ways to prevent, detect, diagnose, and treat this complex disease. As one of 71 National Cancer Institute-designated cancer centers, Hollings continues to attract top cancer researchers from leading institutions across the country who conduct research in the community, laboratory, and clinic.
Lexington Medical Cancer Center is widely recognized for the highest quality of care, to include designations as a Cancer Center of Excellence by the American College of Surgeons Commission on Cancer, a Breast Center of Excellence by the National Accreditation Program for Breast Centers, a Breast Imaging Center of Excellence and a Lung Cancer Screening Center by the American College of Radiology.
About Lexington Medical Center
Lexington Medical Center is a 557-bed hospital in West Columbia, South Carolina. It anchors a health care network that includes five community medical centers and employs more than 7,800 health care professionals. The network includes a cardiovascular program recognized by the American College of Cardiology as South Carolina’s first HeartCARE Center and an accredited Cancer Center of Excellence. The network also has an occupational health center, the largest skilled nursing facility in the Carolinas, an Alzheimer’s care center and 70 physician practices. Lexington Medical Center operates one of the busiest Emergency departments in South Carolina, treating nearly 100,000 patients each year. The hospital delivers more than 4,000 babies each year and performs more than 25,000 surgeries.
About MUSC Hollings Cancer Center
MUSC Hollings Cancer Center is South Carolina’s only National Cancer Institute-designated cancer center with the largest academic-based cancer research program in the state. The cancer center comprises more than 120 faculty cancer scientists and 20 academic departments. It has an annual research funding portfolio of more than $44 million and is dedicated to preventing and reducing the cancer burden across South Carolina. Hollings offers state-of-the-art diagnostic capabilities, therapies and surgical techniques within multidisciplinary clinics that include surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and other specialists equipped for the full range of cancer care, including more than 200 clinical trials across South Carolina. For more information, visit hollingscancercenter.musc.edu.